Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6245811rdf:typepubmed:Citationlld:pubmed
pubmed-article:6245811lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6245811lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:6245811lifeskim:mentionsumls-concept:C0596901lld:lifeskim
pubmed-article:6245811lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:6245811lifeskim:mentionsumls-concept:C0017906lld:lifeskim
pubmed-article:6245811lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6245811pubmed:issue3lld:pubmed
pubmed-article:6245811pubmed:dateCreated1980-7-12lld:pubmed
pubmed-article:6245811pubmed:abstractTextPeriodate oxidation of human peripheral blood lymphocytes followed by reduction with 3H labelled sodium borohydride and acidic hydrolysis generates N-AN 7, glycerol and propane 1-2 diol. This indicates that sialyl, fucosyl and probably galactosyl residues are oxidized by periodate. Neuraminidase-treated lymphocytes exhibit decreased N-AN 7 levels, increased N-AN 8 levels and increased glycerol levels. Such results were neither found with mouse splenocytes nor with calf lymph node cells.lld:pubmed
pubmed-article:6245811pubmed:languagefrelld:pubmed
pubmed-article:6245811pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6245811pubmed:citationSubsetIMlld:pubmed
pubmed-article:6245811pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6245811pubmed:statusMEDLINElld:pubmed
pubmed-article:6245811pubmed:monthJanlld:pubmed
pubmed-article:6245811pubmed:issn0567-655Xlld:pubmed
pubmed-article:6245811pubmed:authorpubmed-author:AgnerayJJlld:pubmed
pubmed-article:6245811pubmed:authorpubmed-author:DurandGGlld:pubmed
pubmed-article:6245811pubmed:authorpubmed-author:GuenounouMMlld:pubmed
pubmed-article:6245811pubmed:authorpubmed-author:BanchereauJJlld:pubmed
pubmed-article:6245811pubmed:authorpubmed-author:DanoisDDlld:pubmed
pubmed-article:6245811pubmed:issnTypePrintlld:pubmed
pubmed-article:6245811pubmed:day21lld:pubmed
pubmed-article:6245811pubmed:volume290lld:pubmed
pubmed-article:6245811pubmed:ownerNLMlld:pubmed
pubmed-article:6245811pubmed:authorsCompleteYlld:pubmed
pubmed-article:6245811pubmed:pagination191-4lld:pubmed
pubmed-article:6245811pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:6245811pubmed:meshHeadingpubmed-meshheading:6245811-...lld:pubmed
pubmed-article:6245811pubmed:meshHeadingpubmed-meshheading:6245811-...lld:pubmed
pubmed-article:6245811pubmed:meshHeadingpubmed-meshheading:6245811-...lld:pubmed
pubmed-article:6245811pubmed:meshHeadingpubmed-meshheading:6245811-...lld:pubmed
pubmed-article:6245811pubmed:meshHeadingpubmed-meshheading:6245811-...lld:pubmed
pubmed-article:6245811pubmed:meshHeadingpubmed-meshheading:6245811-...lld:pubmed
pubmed-article:6245811pubmed:year1980lld:pubmed
pubmed-article:6245811pubmed:articleTitle[Effect of a mitogenic concentration on membrane glycoconjugates of human lymphocytes].lld:pubmed
pubmed-article:6245811pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6245811pubmed:publicationTypeEnglish Abstractlld:pubmed